XNAS
TLSI
Market cap139mUSD
Jul 09, Last price
3.89USD
1D
5.71%
1Q
-7.82%
IPO
-67.58%
Name
Medtech Acquisition Corp
Chart & Performance
P/E
—
P/S
3.27
EPS
—
Div Yield, %
—
Shrs. gr., 5y
4.40%
Rev. gr., 5y
%
Revenues
45m
+53.41%
Net income
-39m
L+18.04%
CFO
-18m
L-55.90%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MedTech Acquisition Corporation currently has no significant active business operations. The firm's stated intention is to pursue and finalize a business combination — which could involve a merger, stock exchange, asset acquisition, or other forms of corporate restructuring — with one or more enterprises in the U.S. healthcare industry. Established in 2020, its corporate base is situated in Greenwich, Connecticut.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||